The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it’s charging up to $520 a vial for remdesivir

Follow your first journalist

Create a free Journa account

Search and follow 52.983 automatically recognized authors and receive the latest news of the journalists you follow in a convenient newsfeed and in your inbox. Want to know more?

Already have an account? Log in with Linkedin

Are you a journalist? Create a profile

By signing up you agree to the terms and conditions and the privacy policy.

Article

Andrew Dunn for Business Insider

Jun 29 ’20

The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it’s charging up to $520 a vial for remdesivir

We found this article at:

www.businessinsider.nl/gilead-sciences-sets-price-for-coronavirus-drug-remdesivir-2020-6/

Follow your first journalist

Create a free Journa account

Article

The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it’s charging up to $520 a vial for remdesivir

auteur

Get notified of new articles from this auteur

Andrew Dunn